Two independent modes of kidney stone suppression achieved by AIM/CD5L and KIM-1

The prevalence of kidney stones is increasing and its recurrence rate within the first 5 years is over 50%. No treatments that prevent the occurrence/recurrence of stones have reached the clinic. Here, we show that AIM (also called CD5L) suppresses stone development and improves stone-associated phy...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuura, Kyohei, Maehara, Natsumi, Hirota, Aika, Eguchi, Ayaka, Yasuda, Keisuke, Taniguchi, Kaori, Nishijima, Akemi, Matsuhashi, Nobuyuki, Shiga, Yoshiyuki, Ishii, Rumi, Iguchi, Yasuhiro, Tanabe, Kazunari, Arai, Satoko, Miyazaki, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349198/
https://www.ncbi.nlm.nih.gov/pubmed/35922481
http://dx.doi.org/10.1038/s42003-022-03750-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349198/
https://www.ncbi.nlm.nih.gov/pubmed/35922481
http://dx.doi.org/10.1038/s42003-022-03750-w

Ejemplares similares